Role of Antioxidants Supplementation in Chronic Pancreatitis

Learn more about:
Related Clinical Trial
Determinants of Depression and Its Impact on Quality of Life in Patients With Chronic Pancreatitis Prospective Registry Of Therapeutic EndoscopiC ulTrasound Intermittent Fasting for Pancreatitis Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies, the PROCEED Study Relationship of CP and AP Personalized Education and Pain Response in Chronic Pancreatitis A Prospective Cohort Study of Large Pancreatic Radiolucent Stone Risk Factors for Post-ESWL and Post-ERCP Pancreatitis Intraductal Liposomal Bupivacaine for Chronic Pancreatitis An Observational Study on the Natural Course of Chronic Pancreatitis Predictors of Pain Relief in Chronic Pancreatitis Undergoing ESWL Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study Malnutrition in Chronic Pancreatitis, Trans-sectoral Study Project Survival-Prospective Biomarker Discovery Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study Volatiles in Breath and Headspace Analysis – Diagnostic Markers Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis Cancer in Patients With Gabapentin (GPRD) A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma Rectal Indomethacin to Prevent Post ESWL-pancreatitis T-EUS for Gastrointestinal Disorders: A Multicenter Registry Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool Contrast EUS of the Pancreas Idiopathic Recurrent Acute Pancreatitis (IRAP) Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis Endoscopic Ultrasound (EUS) Processor Comparison The North American Pancreatitis Study A Prospective Observational Study of TPIAT Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation Economisation of Whipple Resection Using an Ultrasonic Dissection Device Biospecimens for Identification of Diseases of the Pancreas. Diagnosis of Bile Duct Strictures Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT Prospective Study of Celiac Block Injection: 1 vs. 2 Online Health Assessment to Support Comprehensive Care Needle-based Confocal Endomicroscopy Examination of Pancreatic Masse Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Extracorporeal Shock Wave Lithotripsy Versus Single Operator Pancreatoscopy and Intraductal Lithotripsy for the Treatment of Pancreatic Duct Stones Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer Mesenchymal Stem Cell and Islet Co-transplantation Analysis of Graft Function Following Autologous Islet Transplantation Carbon Monoxide-Saturated Medium for Islet Isolation Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses Endoscopic Ultrasound Elastography in Pancreatic Masses Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis A Prospective Study of Natural History of Pancreatitis Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain ESWL Versus ESWL and Endoscopic Treatment SpHincterotomy for Acute Recurrent Pancreatitis A Prospective Study of EUS Guided Celiac Block A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 Examining Macrophage Influx and Vascularization in Chronic Pancreatitis Enzyme Suppletion in Exocrine Pancreatic Dysfunction ESWL vs. Pancreatoscopy-guided Lithotripsy for Painful Chronic Calcific Pancreatitis Internet-based Pain Self-management for Persons With Acute Recurrent and Chronic Pancreatitis Pain Comparison of Extracorporeal Shock Wave Lithotripsy (ESWL) Alone and ESWL Plus Endoscopy for Painful Chronic Pancreatitis A Phase IIa Study With Escalating Dose of MS1819-SD Decrease of Recurrent Pancreatitis Celiac Plexus Block for Chronic Pancreatitis RCT Pancreatic Perfusion Using Secretin and MRI Viokase 16, Viokase16 Plus Nexium and Nexium Alone Prospective Study on Endoscopic Ultrasound (EUS) Celiac Bloc Efficacy in Chronic Pancreatitis Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis Endoscopic Stenting for Chronic Abdominal Pain WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) The Incretin Effect in Patients With Chronic Pancreatitis Extracorporeal Shock Wave Lithotripsy and Endotherapy for Pain in Chronic Pancreatitis Percutaneous Lesioning Splanchnic Nerves in Patients With Chronic Pancreatitis Fibro-inflammatory Progression From Acute to Chronic Pancreatitis CT Pancreas Perfusion CPB Versus Sham Treatment for Pain Management in Small Duct Chronic Pancreatitis Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption The Natural History of Chronic Pancreatitis BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency Is There an Association Between Chronic Pancreatitis and Pulmonary Function Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Assessing the Utility of Cognitive Behavioral Therapy for Pain Control in Patients With Chronic Pancreatitis QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing Pain and Chronic Pancreatitis – Clinical End Experimental Studies A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis Endoscopic Treatment of Biliary Stricture Caused by Chronic Pancreatitis Trial of Indomethacin in Chronic Pancreatitis The Diagnosis of Chronic Pancreatitis Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality Effect of Acetyl-L-carnitine on Chronic Pancreatitis Establishing Standards for Normal Pancreatic EUS The Long Term Outcomes of Micronutrient Antioxidant Supplementation in Patients With Chronic Pancreatitis Secretin Infusion for Pain Due to Chronic Pancreatitis Self-expandable, Fully Covered Metal Stents in Biliary Strictures Due to Chronic Pancreatitis Elastography in the Diagnosis of Chronic Pancreatitis The PASTEC Study: Endoscopic Stenting Versus Surgery for the Treatment of Bile Duct Stricture in Chronic Pancreatitis Covered Metal Stent for Benign Biliary Stricture Caused by Chronic Pancreatitis tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a Randomized Control Trial Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies Endoscopic Versus Surgical Treatment of Chronic Pancreatitis Classification and Comparison of Early-onset and Late-onset Idiopathic Chronic Pancreatitis Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis Novel Breath Test to Detect Early Stage Chronic Pancreatitis Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions Dietary Soy Isoflavones In Chronic Pancreatitis Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis Nerve Growth Factor in Chronic Pancreatitis Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) Role of Antioxidants Supplementation in Chronic Pancreatitis Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis Bone Disease in Chronic Pancreatitis: A Complex Phenomenon Correlation of Chronic Pancreatitis Pathology Features With Endoscopic Ultrasound (EUS) Criteria

Brief Title

Role of Antioxidants Supplementation in Chronic Pancreatitis

Official Title

Effect of Antioxidant Supplementation on Pain, Antioxidant Profile and Oxidative Stress in Patients With Chronic Pancreatitis

Brief Summary

      Chronic pancreatitis is a progressive inflammatory disease of the pancreas that presents with
      abdominal pain and in late stages may cause diabetes and malnutrition. The pain may be
      incapacitating and may affect patients physically, mentally and socially. Pain due to chronic
      pancreatitis is difficult to treat. Oxidative stress and free radical mediated injury has
      been shown to cause pancreatic inflammation. It has been shown that patients with chronic
      pancreatitis are deficient in micronutrients and natural antioxidants such as b-carotene,
      vitamin E and C etc. Studies have suggested that antioxidant supplementation may help to
      combat pain in these patients. Antioxidant supplementation may decrease the oxidative stress
      and boost the antioxidant status, thereby resulting in pain relief. The investigators have
      planned to perform a trial to study the effect of antioxidant supplementation on pain relief
      in patients with chronic pancreatitis.
    

Detailed Description

      INTRODUCTION Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas
      accompanied by abdominal pain and in late stages, by exocrine and endocrine insufficiency.
      The etiology of CP include alcohol abuse, hereditary, ductal obstruction, tropical
      pancreatitis, systemic diseases (systemic lupus erythematosus and cystic fibrosis etc.), and
      idiopathic. Alcohol abuse accounts for 70-80% of cases of chronic pancreatitis in the West
      and about 40% in India. The intensity of injury depends on the duration and amount of alcohol
      consumed. Hereditary pancreatitis transmitted as an autosomal dominant trait accounts for a
      small subset of all cases of CP, and occurs due to mutation in cationic trypsinogen gene.
      Pancreatic duct obstruction may be secondary to trauma, pseudocysts, calcific stones or
      tumors and leads to obstructive CP (1). Tropical pancreatitis is a condition of unknown
      etiology that is seen predominantly in south India and other tropical areas of the World.
      Young patients are commonly affected with this disease. Cassava consumption had been proposed
      as an etiological factor due to its cyanogenic glycoside content however no epidemiological
      study has proved this hypothesis (2). Malnutrition has been suggested as an etiological
      factor in tropical pancreatitis. Idiopathic pancreatitis accounts for a substantial number of
      cases.

      Many recent studies have emphasized a role for Reactive Oxygen Radicals (ROR) in the
      development of oxidative stress and hence inflammation in the pathogenesis of chronic
      pancreatitis. Increased oxidative stress probably results from increased exposure to
      xenobiotics. Xenobiotics are chemical substances present in the environment to which human
      beings are constantly exposed. It is conceivable that many of these xenobiotics are
      metabolized in pancreas that contains cytochrome P450 (CYP450) enzymatic system. The
      metabolism of xenobiotics occurs through two phases, Phase I and Phase II. Phase I metabolism
      may result in 'bioactivation' of the xenobiotics, in turn activating CYP system. Phase II
      involves attachment of biotransformed compound to a biological molecule that makes it more
      polar and thus easier to excrete. The metabolism of xenobiotics places an oxidative stress
      and can overwhelm the natural antioxidant defense of the body. The resultant production of
      the free radicals may play an important role in the pathogenesis of CP (2). Over induction of
      this enzyme can cause increased utilization of glutathione (GSH), which causes irreversible
      loss of glutathione. Moreover glutathione serves as a reservoir for cysteine/cystine required
      for disulphide synthesis for pancreatic digestive proteins. This further aggravates the
      situation. Three types of cytochrome enzymes are induced through xenobiotics. CYP2E1 has been
      specifically examined in the context of liver injury. CYP1A metabolizes smoke constituents
      and potent carcinogens such as benzo(a)pyrene. Cytochrome 3A is inducible by reactive oxygen
      species generated from aflatoxin B1. Alcohol, nicotine from cigarette smoke and other forms
      of tobacco consumption and industrial pollutants all are considered as xenobiotics and
      overwhelm the detoxification capacity of cytochrome CYP450 system (3). The CYP induction
      increases heme and heme-oxygenase thus buttressing the antioxidant defenses. The free radical
      peroxidation products may act as second messengers and block exocytosis leading to increased
      autophagy and crinophagy thus diverting the pancreatic enzymes into interstitium. This leads
      to degranulation of mast cells inducing inflammation mediated by chemotaxis. The synthesis of
      enzyme proteins in pancreas also produces H2O2, which also induces free radical production.
      Furthermore the depressed methionine trans-sulphuration pathway induces CYP as well. The free
      radicals generated from all these processes induce oxidative stress, which is implicated in
      damage to cell membranes due to lipid peroxidation. Above all, if the antioxidant levels of
      an individual are may be low due to either low intake or depletion during oxidative stress.
      Some studies also indicate that free radicals cause disintegration of antioxidative enzymes
      if over exposed to them.

      However, the role of oxidative stress still not fully explained in that whether the oxidative
      stress is the cause of chronic pancreatitis or a consequence of it. This can be established
      by two observations: 1) If the oxidative stress is noted before the onset of disease and 2)
      If the disease symptoms are relieved by supplementation with antioxidants. Patients with
      alcoholic pancreatitis have been shown to have an increased oxidative stress. Supplementation
      with antioxidants hence decreases the production of such free radicals and may be beneficial
      to patients with CP (4).

      A study by Braganza et al has shown that CP involves oxidative stress in-patients with CP
      (5). This was the first study to indicate the role of free radicals in the pathogenesis of
      chronic pancreatitis. However, the mechanism by which it occurs is still unclear. The
      preliminary studies show that malondialdehyde (MDA); a marker of peroxidation secondary to
      oxidative stress increases during CP.

      In the present proposed study, the aim is to find out if there is increased oxidative stress
      in patients with CP and if supplementation with antioxidants relieves pain in them in order
      to establish a relationship between oxidant stress and pathophysiology of chronic
      pancreatitis.

      Objectives

        1. To evaluate the effect of antioxidant supplementation given daily on pain relief in
           chronic pancreatitis during the 6 months of therapy as compared to a placebo.

        2. To assess the improvement in oxidative stress and antioxidant profile in these patients
           during 6 months of antioxidant supplementation by measuring markers of oxidative stress
           and blood antioxidant levels.

      Material and methods Study Design: Double blind randomized controlled trial Patients All
      consecutive patients with chronic pancreatitis attending the pancreas clinic at AIIMS will be
      included in the study as per the inclusion criteria. The diagnosis of CP will be made if
      there is evidence of CP on imaging studies including plain film of the abdomen,
      Ultrasonography, Computerized tomography (CT) scan, endoscopic retrograde
      cholangiopancreatography (ERCP), and magnetic resonance imaging (MRI) scan. Also
      hematological tests, biochemical investigations will be done as part of diagnostic work-up.

      All patients will undergo detailed clinical evaluation including detailed family history of
      pancreatic diseases and diabetes. The WHO criteria will be used to diagnose diabetes. The
      patients will also be inquired about their dietary history and addiction to tobacco or
      alcohol. Patients will be explained the purpose of study clearly and consent forms will be
      duly signed by them. The patients will be regularly followed up in pancreas clinic at All
      India Institute of Medical Sciences, New Delhi. All the patients will be treated in the
      standard manner including medical, endoscopic and surgical treatment as and when indicated.

      Inclusion criteria:

      CP with significant pain i.e. at least one episode of pain in a month requiring oral
      analgesic or one episode of severe pain in last three months requiring hospitalization.

      Sample size calculation Sample size is calculated on the basis of probability sampling
      methods. For 80% power at a significance level of 5% (a = 0.05), a sample size of 100 in each
      arm would be required.

      Randomization and blinding Randomization of treatment allocation largely ensures unbiased
      treatment comparison. A simple randomization scheme for treatment allocation will be done
      using a table of random numbers by a Statistician/ Epidemiologist not associated with conduct
      of the study. He/she will label the boxes of treatment with individual patient numbers from
      1-200 according to the randomization scheme. This person will keep the assignment code at a
      safe place; the code will be available to the investigator only at the end of the trial.
      These will be serially opened as new patients are recruited into the study. Double blinding
      will be done to ensure minimum bias i.e. blinding of researcher and clinician attending
      patients to the randomization process so that allocation and outcome evaluation are not
      affected and blinding of patients to the identity of the drug or intervention they are
      receiving. The inert placebo, which will be identical to the active drug in packaging,
      appearance and schedule of administration.

      Intervention One group will be given antioxidant supplementation and the other group will be
      placebo. The antioxidant intervention will be daily doses of 600 mg organic selenium, 0.54 g
      vitamin C, 9000 IU B-carotene, 270 IU vitamin E and 2 g methionine. Both the groups will be
      supplemented with the pancreatic enzymes. The enzyme will be administered as capsules, each
      containing 10,000 units. Three capsules (30,000) units will be required per meal thereby
      making it to 90,000 units per day.

      Follow up assessment during study period:

      Clinical:

        -  Assessment of painful days and requirement of oral/ IV analgesic or hospitalization in a
           month will be done. The patients will be provided with a pain diary so as to get the
           correct data.

        -  Any other symptoms either due to primary disease i.e. CP or considered due to the
           intervention will be duly recorded.

             -  Pain assessment and clinical examination will be done at each visit of patient to
                the clinic while USG, ERCP, CT or X-ray will be done as and when required.

      Markers of oxidative stress

        -  MDA Marker of antioxidant capacity or defense

        -  Superoxide dismutase (SOD), Total glutathione, Ferric Reducing Assay of Plasma (FRAP)
           Markers of intervention compliance

        -  Vitamins A, E, C *All the biochemical investigations will be done at baseline, 1 and 6
           months of intervention.

      All the samples will be light protected and purged with nitrogen to retard deterioration from
      oxidation of substrates during storage.

      Statistics Descriptive statistics i.e. mean, standard deviation and frequency distribution
      will be calculated for each variable in the study. To compare the two groups, Student 't'
      test (quantitative) and chi square test (qualitative) wherever applicable will be applied. To
      see trend within the variable 2-way analysis of variance (parametric as well as
      non-parametric, whichever is applicable) will be done post-hoc analysis. P value < 0.05 will
      be considered as statistical significant. Statistic software SPSS 7.5 for Windows will be
      used for statistical analysis.

      Study Outcome Primary Outcome

      1. Reduction in the number of painful days per month due to chronic pancreatitis.

      Secondary Outcome

        1. Decrease in no. of severe attacks requiring hospitalization.

        2. Percentage of patients who are pain-free.

        3. Increase in markers of antioxidant defense in the intervention group compared to placebo
           group and decrease in oxidative stress parameters in patients after intervention
           compared to placebo.

      References:

        1. Pitchumoni CS, Mohan AT. Pancreatic stones. Gastroenterol. Clin. North Amer. 1990: 19;
           873-893.

        2. Walling MA. Xenobiotic metabolism, oxidant stress and chronic pancreatitis: Focus on
           glutathione. Digestion 59 (Suppl4): 13-24, 1998.

        3. Lin Y, Tamakoshi A et al. 2000. Cigarette smoke as a risk factor for chronic
           pancreatitis: A case control study in Japan. Pancreas. 21 (2), 109-114.

        4. Uden S, Schofield D, Miller PF, Day JP Bottiglier T and Braganza JM. 1992. Aliment
           Pharmacol Ther. 6, 229-240.

        5. Braganza JM. A framework for etiogenesis of chronic pancreatitis. Digestion: 1998; 59
           (suppl. 4): 1-12.
    

Study Phase

Phase 3

Study Type

Interventional


Primary Outcome

Reduction in the number of painful days per month due to chronic pancreatitis

Secondary Outcome

 Decrease in no. of severe attacks requiring hospitalization

Condition

Chronic Pancreatitis

Intervention

Antioxidants

Study Arms / Comparison Groups

 Antioxidants
Description:  Intervention was done with antioxidants

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Dietary Supplement

Estimated Enrollment

127

Start Date

October 2003

Completion Date

October 2006


Eligibility Criteria

        Inclusion Criteria:

          -  CP with significant pain i.e., at least one episode of pain in a month requiring oral
             analgesic or one episode of severe pain in last three months requiring hospitalization

        Exclusion Criteria:

          -  Painless disease

          -  Current pain more likely due to non-pancreatic origin

          -  If the patient already has an intervention in the form decompressive therapy i.e.,
             surgery or endoscopic sphincterotomy/ stenting or ESWL

          -  Systemic conditions like CRF, malignancy, hypertension, and pregnancy

          -  Complications like pseudocyst, pancreatic abscess

          -  Patients who would have received antioxidants in the preceding 4 weeks

          -  Narcotic addicts

          -  Uncontrolled diabetes

          -  Comorbid conditions like liver diseases
      

Gender

All

Ages

12 Years - 70 Years

Accepts Healthy Volunteers

No

Contacts

Payal Bhardwaj, MSc, , 

Location Countries

India

Location Countries

India

Administrative Informations


NCT ID

NCT00319358

Organization ID

IR-131



Study Sponsor

All India Institute of Medical Sciences, New Delhi


Study Sponsor

Payal Bhardwaj, MSc, Principal Investigator, dept. of Gastroenterology, A.I.I.M.S. , New Delhi


Verification Date

January 2009